ECVT Stock Analysis: Ecovyst | NYSE

Specialty Chemicals | NYSE, USA | Market Cap: 1.107m USD | 12M Return: 13.3% | US27923Q1094 | Charts, Fundamentals & Technical Analysis

Sulfuric Acid, Alkylate Logistics, Water Treatment, Refinery Services
Total Rating 44
Safety 65
Buy Signal -0.47
Specialty Chemicals
Industry Rotation: -2.6
Market Cap: 1.11B
Avg Turnover: 13.0M
Risk 3d forecast
Volatility34.4%
VaR 5th Pctl5.82%
VaR vs Median2.79%
Reward TTM
Sharpe Ratio0.42
Rel. Str. IBD18
Rel. Str. Peer Group38.5
Character TTM
Beta1.040
Beta Downside0.896
Hurst Exponent0.436
Drawdowns 3y
Max DD52.20%
CAGR/Max DD0.01
CAGR/Mean DD0.02
EPS (Earnings per Share) EPS (Earnings per Share) of ECVT over the last years for every Quarter: "2021-09": 0.19, "2021-12": 0.17, "2022-03": 0.15, "2022-06": 0.22, "2022-09": 0.23, "2022-12": 0.25, "2023-03": 0.06, "2023-06": 0.29, "2023-09": 0.19, "2023-12": 0.22, "2024-03": 0.04, "2024-06": 0.12, "2024-09": 0.14, "2024-12": 0.28, "2025-03": 0.01, "2025-06": 0.1, "2025-09": 0.19, "2025-12": 0.28, "2026-03": 0.11, "2026-06": 0.2,
EPS CAGR: -3.78%
EPS Trend: -21.8%
Last SUE: 0.72
Qual. Beats: 0
Revenue Revenue of ECVT over the last years for every Quarter: 2021-09: 167.428, 2021-12: 170.197, 2022-03: 179.714, 2022-06: 225.172, 2022-09: 232.533, 2022-12: 182.74, 2023-03: 160.874, 2023-06: 184.11, 2023-09: 173.326, 2023-12: 172.808, 2024-03: 160.537, 2024-06: 182.82, 2024-09: 179.175, 2024-12: 181.961, 2025-03: 143.109, 2025-06: 200.128, 2025-09: 204.907, 2025-12: 199.433, 2026-03: 214.952, 2026-06: 250,
Rev. CAGR: 6.87%
Rev. Trend: 78.9%
Last SUE: 0.93
Qual. Beats: 2

Warnings

Altman Z'' In Financial Distress Zone
Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 8.8 years of data

Jan +0.8% 2
Feb +1.0% 15
Mar +3.1% 18
Apr +1.2% 14
May -0.3% 2
Jun +1.7% 0
Jul +1.4% 17
Aug -5.8% 42
Sep -3.1% 46
Oct -1.4% 18
Nov +0.2% 2
Dec +1.3% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: ECVT Ecovyst

Ecovyst Inc. (NYSE: ECVT) is a specialty chemicals company that produces and sells both virgin and regenerated sulfuric acid, serving customers in the United States and international markets. Its products and logistics services support alkylate production for refineries, as well as mining, water treatment, and broader industrial applications. Sulfuric acid is one of the most widely consumed industrial chemicals globally, and Ecovysts regeneration capabilities position it within the circular economy by reclaiming and reprocessing spent acid rather than producing only new material. The company was originally founded in 1831 as PQ Group Holdings and rebranded as Ecovyst in August 2021; it is headquartered in Wayne, Pennsylvania, and is classified within the GICS Materials sector.

Headlines to Watch Out For
  • Refinery utilization drives virgin sulfuric acid demand
  • Mining sector consumption supports acid pricing
  • Catalyst Technologies margins expand on higher utilization
Piotroski VR-10 (Strict) 6.5
Net Income: -61.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.40 > 1.0
NWC/Revenue: 12.40% < 20% (prev 21.26%; Δ -8.86% < -1%)
CFO/TA 0.10 > 3% & CFO 148.3m > Net Income -61.3m
Net Debt (512.0m) to EBITDA (213.1m): 2.40 < 3
Current Ratio: 1.70 > 1.5 & < 3
Outstanding Shares: last quarter (110.8m) vs 12m ago -4.89% < -2%
Gross Margin: 21.04% > 18% (prev 24.51%; Δ -3.48% > 0.5%)
Asset Turnover: 54.04% > 50% (prev 39.21%; Δ 14.83% > 0%)
Interest Coverage Ratio: 3.28 > 6 (EBIT TTM 79.0m / Interest Expense TTM 24.1m)
Altman Z'' 1.02
A: 0.08 (Total Current Assets 261.3m - Total Current Liabilities 153.5m) / Total Assets 1.42b
B: -0.17 (Retained Earnings -236.5m / Total Assets 1.42b)
C: 0.05 (EBIT TTM 79.0m / Avg Total Assets 1.61b)
D: 0.70 (Book Value of Equity 586.9m / Total Liabilities 833.8m)
Altman-Z'' = 1.02 = BB
Beneish M -2.93
DSRI: 0.88 (Receivables 112.9m/103.5m, Revenue 869.3m/704.4m)
GMI: 1.17 (GM 24.51% / 21.04%)
AQI: 0.82 (AQ_t 0.40 / AQ_t-1 0.49)
SGI: 1.23 (Revenue 869.3m / 704.4m)
TATA: -0.15 (NI -61.3m - CFO 148.3m) / TA 1.42b)
Beneish M = -2.93 (Cap -4..+1) = A
What is the price of ECVT shares?

As of September 05, 2026, the stock is trading at USD 10.21 with a total of 776,632 shares traded. Over the past week, the price has changed by +0.99%, over one month by -15.69%, over three months by -21.04% and over the past year by +13.32%.

Current recommended Stop Loss: 9.50 (which is 7% or 2 ATR below the current price).

Is ECVT a buy, sell or hold?

Ecovyst has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy ECVT.

  • StrongBuy: 4
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the ECVT price?
Analysts Target Price 15.5 51.8%
Ecovyst (ECVT) - Fundamental Data Overview as of 30 August 2026
Market Cap USD = 1.11b (1.11b USD * 1.0 USD.USD)
P/E Trailing = 43.9565
P/E Forward = 14.556
P/S = 1.2732
P/B = 1.893
Revenue TTM = 869.3m USD
EBIT TTM = 79.0m USD
EBITDA TTM = 213.1m USD
Long Term Debt = 493.0m USD (from longTermDebt, last quarter)
Short Term Debt = 13.2m USD (from shortTermDebt, last quarter)
Debt = 599.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 53.4m
Net Debt = 512.0m USD (calculated: Debt 599.8m - CCE 87.8m)
Enterprise Value = 1.62b USD (1.11b + Debt 599.8m - CCE 87.8m)
Interest Coverage Ratio = 3.28 (Ebit TTM 79.0m / Interest Expense TTM 24.1m)
EV/FCF = 22.42x (Enterprise Value 1.62b / FCF TTM 72.2m)
FCF Yield = 4.46% (FCF TTM 72.2m / Enterprise Value 1.62b)
FCF Margin = 8.31% (FCF TTM 72.2m / Revenue TTM 869.3m)
Net Margin = -7.05% (Net Income TTM -61.3m / Revenue TTM 869.3m)
Gross Margin = 21.04% ((Revenue TTM 869.3m - Cost of Revenue TTM 686.4m) / Revenue TTM)
Gross Margin QoQ = 19.92% (prev 15.94%)
Tobins Q-Ratio = 1.14 (Enterprise Value 1.62b / Total Assets 1.42b)
Interest Expense / Debt = 4.01% (Interest Expense 24.1m / Debt 599.8m)
Taxrate = 28.19% (4.20m / 14.9m)
NOPAT = 56.8m (EBIT 79.0m * (1 - 28.19%))
Current Ratio = 1.70 (Total Current Assets 261.3m / Total Current Liabilities 153.5m)
Debt / Equity = 1.02 (Debt 599.8m / totalStockholderEquity, last quarter 586.9m)
Debt / EBITDA = 2.40 (Net Debt 512.0m / EBITDA 213.1m)
Debt / FCF = 7.09 (Net Debt 512.0m / FCF TTM 72.2m)
Total Stockholder Equity = 593.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.81% (Net Income -61.3m / Total Assets 1.42b)
RoE = -10.33% (Net Income TTM -61.3m / Total Stockholder Equity 593.4m)
RoCE = 7.28% (EBIT 79.0m / Capital Employed (Equity 593.4m + L.T.Debt 493.0m))
RoIC = 4.59% (NOPAT 56.8m / Invested Capital 1.24b)
WACC = 7.26% (E(1.11b)/V(1.71b) * Re(9.64%) + D(599.8m)/V(1.71b) * Rd(4.01%) * (1-Tc(0.28)))
Discount Rate = 9.64% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -90.75 | Cagr: -2.54%
[DCF] Terminal Value 73.26% ; FCFF base≈76.9m ; Y1≈68.1m ; Y5≈56.0m
[DCF] Fair Price = 3.51 (EV 896.6m - Net Debt 512.0m = Equity 384.6m / Shares 109.5m; r=8.35% [WACC [floored]]; 5y FCF grow -14.09% → 2.50% )
EPS Correlation: -21.80 | EPS CAGR: -3.78% | SUE: 0.72 | # QB: 0
Revenue Correlation: 78.85 | Revenue CAGR: 6.87% | SUE: 0.93 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.21 | Chg30d=+0.05% | Revisions=+0% | Analysts=5
EPS current Year (2026-12-31): EPS=0.68 | Chg30d=+0.77% | Revisions=+0% | GrowthEPS=+75.4% | GrowthRev=+40.5%
EPS next Year (2027-12-31): EPS=0.87 | Chg30d=-1.06% | Revisions=+0% | GrowthEPS=+27.5% | GrowthRev=+4.0%
[Analyst] Revisions Ratio: +0% (up=0, down=0)